Skip to main navigation Skip to search Skip to main content

A randomized, open-label, single-dose study to evaluate the safety and pharmacokinetics of two formulations containing 40 mg of fexuprazan in healthy Korean subjects

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalInternational Journal of Clinical Pharmacology and Therapeutics
StatePublished - 2026.03.1

Cite this